ITOS - Esperion sinks after Stifel downgrade Community Health adds another bull; in today's healthcare analyst action

Esperion sheds nearly a third on Stifel cut Esperion Therapeutics (ESPR) has lost ~32.8% in the early hours after Stifel downgraded the stock to hold from buy noting “we don't think this story gets any better soon.”Esperion’s Q1 2021 financials came below expectations leading the stock to lose 30% in after-hours trading yesterday.Seeing little signs of sales acceleration for cholesterol therapies Nexletol and Nexlizet in the near term, the analyst Derek Archila lowers the price target by ~45.9% to $20.00 per share implying a downside of ~21.8% to the last close.Declining credit risk highlighted as Jefferies upgrades Community Health Community Health Systems (CYH) has added ~6.2% in the premarket after Jefferies upgraded the stock to buy from hold. After a ~63.6% boost, the price target of $18.00 per share indicates a premium of ~44.1% to the last close.“The stock is positioned for multiple expansion and upward EBITDA revisions,” the analyst Brian Tanquilut wrote citing among other things

For further details see:

Esperion sinks after Stifel downgrade, Community Health adds another bull; in today’s healthcare analyst action